Term
factors that regulate sleep |
|
Definition
age sleep history drug ingestion circadian rhythms |
|
|
Term
factors that regulate sleep-neurotransmitters |
|
Definition
catecholamines serotonin histamine acetylcholine adenosine GABA |
|
|
Term
factors that regulate sleep-neuromodulators |
|
Definition
growth hormone prolactin melatonin endogenous peptides |
|
|
Term
ligands acting at the BZD binding site |
|
Definition
benzodiazepines non-benzodiazepines BZD antagonists Inverse BZD agonists |
|
|
Term
ligands acting at other sites |
|
Definition
barbiturates alcohol GABA blockers GABA agonist etomidate and propofol |
|
|
Term
chlordiazepoxide (Librium) |
|
Definition
benzodiazepine slow elimination rate 1st benzodiazepine used as an anxiolytic and for alcohol withdrawal accumulation of metabolites |
|
|
Term
|
Definition
benzodiazepines slow elimination rate prototypical benzodiazepine used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders, accumulation of metabolites |
|
|
Term
|
Definition
benzodiazepines slow elimination rate used as a hypnotic, accumulation of metabolites |
|
|
Term
|
Definition
benzodiazepines slow elimination rate used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders accumulation of metabolites |
|
|
Term
|
Definition
benzodiazepines slow elimination rate used as a hypnotic accumulation of metabolites |
|
|
Term
|
Definition
benzodiazepines slow elimination rate currently unavailable in the US used as an anxiolytic |
|
|
Term
|
Definition
benzodiazepines intermediate eliminate rate withdrawal symptoms can present if abrupt discontinuation occurs, used as n anxiolytic and anesthetic |
|
|
Term
|
Definition
benzodiazepines intermediate eliminate rate used as an anxiolytic and as a hypnotic |
|
|
Term
clonazepam (Klonopin) C-IV |
|
Definition
benzodiazepines intermediate eliminate rate tolerance may develop with prolonged use, used as an anticonvulsant |
|
|
Term
|
Definition
benzodiazepines intermediate eliminate rate used as an anxiolytic and for alcohol withdrawal |
|
|
Term
|
Definition
benzodiazepines intermediate eliminate rate used as a short-term hypnotic |
|
|
Term
|
Definition
benzodiazepines intermediate eliminate rate discontinued used as a short-term hypnotic |
|
|
Term
|
Definition
benzodiazepines rapid elimination rate rapid anesthesia |
|
|
Term
triazolam (Halcion, discontinued) |
|
Definition
used as a short-term hypnotic |
|
|
Term
|
Definition
benzodiazepine antagonist therapeutic use --> BZD overdose initial dose- 0.2 mg IV over 30 sec, if desired consciousness not obtained increase to 0.3mg IV over 30 sec max total cumulative dose- 3 mg (usual range 1-3mg) side effects: induced convulsions, panic attacks, agitation, confusion, nausea and vomiting, headache |
|
|
Term
zolpidem (Ambien, Ambien CR) C-IV |
|
Definition
non-benzodiazepine short-term treatment of insomnia with difficulty of sleep-onset ambien CR for sleep maintenance "A-minus" and "Zombie pills" dangerous aid for sexual assault teen party drug |
|
|
Term
|
Definition
non-benzodiazepine short-term treatment of insomnia MOA: facilitate GABA-mediated inhibition, act on GABAa receptor-BZ1 rapid acting rapidly eliminated little tolerance or dependence short-term treatment- 7 to 10 days |
|
|
Term
|
Definition
non-benzodiazepine MOA: facilitate GABA active enantiomer of zopiclone- 50x greater affinity treatment of insomnia- able to sleep all through the night with fewer interruptions, approved for long-term use (low tolerance over time, based on 6 mo study) temporary side effect: unpleasant metallic taste |
|
|
Term
|
Definition
benzodiazepine not available in the US "roofies" DEA recommends changing to C-I anterograde amnesia- dangerous aid for sexual assault |
|
|
Term
|
Definition
anticonvulsants phenobarbital (Luminal) mephobarbital (Mebaral) |
|
|
Term
short to intermediate acting barbiturates |
|
Definition
sedative-hypnotics amobarbital (Amytal) butabarbital (Butisol Sodium) pentobarbital (Nembutal) secobarbital (Seconal) aprobarbital (Alurate) |
|
|
Term
ultra-short acting barbiturates |
|
Definition
IV anesthetics thiopental (Pentothal) methohexital (Brevital Sodium) thiamylal (Surital) |
|
|
Term
|
Definition
GABAb receptor agonist skeletal muscle relaxant (treatment of alcoholism) |
|
|
Term
Gamma-Hydroxybutyric Acid (GHB) |
|
Definition
GABAb receptor agonist central nervous system depressant |
|
|
Term
Phaclofen, Saclofen, and 2-Hydroxysaclofen |
|
Definition
GABAb receptor antagonist |
|
|
Term
Xyrem (Sodium Oxybate, GHB) |
|
Definition
CI-->illicit use CII-->medical use available only to prescribers enrolled in the Xyrem Patient Success Program -dispensed to the patient through a designated centralized pharmacy -patients must be seen every 3 months -rx can be written for a maximum of 3 mo supply -1st Rx can only be written for a 1 mo supply actions -with concomitant stimulant use: decrease excessive daytime sleepiness, increase daytime wakefulness -decrease cataplexy pharmacology: -GABAb, GABAa, and GHB(?) receptors dosing: oral solution (500mg/mL), initial dose- 4.5g/night in 2 divided doses-1st dose given at bedtime, 2nd dose given 2.5 to 4 hours later, doses may be increased or adjusted in 2 week intervals, average dose: 6 to 9 g/night. concerns: mechanism (?), other agents, red tape, abuse and misuse |
|
|
Term
Gamma-Hydroxybutyric Acid (GHB) |
|
Definition
street names: "liquid ecstasy", "Liquid X", "Juice", "Grievous Bodily Harm", "Scoops", "Georgia Home Boy" Background: 1960's to today: anesthetic, fat burner, GH promoter, "Raves", Date Rape, and body building Pharmacology: CNS depression-->dose dependent, dizziness, drowsiness, coma -patients often awaken spontaneously -prodrugs: Gamma-Butryolactone(GBL), 1,4-Butanediol |
|
|
Term
Ramelteon (Rozerem): Melatonin Agonist |
|
Definition
MOA: high affinity for MT1 and MT2 melatonin receptors, receptors located in the suprachiasmatic nucleus (SCN), servse as a "master clock" by regulating circadian rhythms-loss of melatonin in aging and alzheimer's metabolism: CYP1A2, avoid with other CYP1A2 inhibitors-fluvoxamine and ciprofloxacin, use with caution in patients with moderate hepatic impairment and avoid use in patients with severe hepatic impairment treatment of insomnia characterized by difficulty with sleep onset non-controlled substance sleep aid no abuse, withdrawal, or dependency negligible risk for next-day "hangover" effects |
|
|
Term
|
Definition
antidepressant unlabeled/investigational use |
|
|
Term
antihistamines (OTC drugs) |
|
Definition
diphenhydramine doxylamine pyrilamine |
|
|
Term
|
Definition
dietary supplement 5HT precursor withdrawn with market due to contamination-caused eosinophilia-myalgia syndrome |
|
|
Term
|
Definition
nutraceutical traveler's jet lag work shifts-insomnia sleep disturbances signs and symptoms of overdose ataxia-drowsiness |
|
|
Term
lemon balm (Melissa officinalis) |
|
Definition
herb use with caution in patients with thyroid problems |
|
|
Term
valerian (Valerian officinlis) |
|
Definition
herb insomnia hepatotoxicity has been noted |
|
|
Term
|
Definition
matricaria chamomilla matricaria recutita herb mild sedative avoid use in patients with a ragweed allergy use with caution in patients using cytochrome P450 substrates |
|
|
Term
Kava Kava (Piper methysticum) |
|
Definition
herb insomnia possibly hepatotoxic |
|
|
Term
structure activity relationships of benzodiazepines |
|
Definition
1 position alkylation-->source of active metabolites 2 position NH2 or N(CH3)2 is active; oxo is active (i.e. valium) 3 position has decreased activity; 3-OH rapid excretion 4-Nonoxide is active substitution on 5-phenyl has decreased activity 7 position with an electronegative group is good anealating the 1-2 bond with an "electron rich" ring (triazole or imidazole) yields high affinity and decreased half life |
|
|
Term
|
Definition
loss of consciousness and reflexes, nausea and vomiting, headache, seizures, death |
|
|
Term
|
Definition
supportive treatment-no antagonist, other sedative-hypnotics-including alcohol, amnesia, date rape-examinations and counseling |
|
|